Some US FDA Advisory Committee Meetings Likely To Remain Virtual Post-Pandemic
Peter Stein says FDA will set criteria for holding a virtual meeting and will be seeking stakeholder feedback.
You may also be interested in...
Rare Disease Expertise On FDA Advisory Committees Gains Capitol Hill Attention
With Congress watching whether enough experts are on advisory committees for orphan drugs, the US FDA may be pressured into changes.
Adcomm Member Survey Shows Continued Support For Virtual Meetings After Pandemic
Despite acknowledging that fully in-person meetings overall are better, survey respondents said they still want the flexibility that virtual attendance offers.
Pondering The Future Of In-Person Meetings At The US FDA
Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.